Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The authors describe an infant presenting at 2 weeks of age with congenital acute lymphoblastic leukemia who had previously received routine bacille Calmette-Guérin (BCG) vaccination at birth. The risk of BCG dissemination in immunocompromised infants is discussed and the use of antimycobacterial prophylaxis in such cases considered.


Journal article


J Pediatr Hematol Oncol

Publication Date





112 - 115


Antineoplastic Combined Chemotherapy Protocols, BCG Vaccine, Cicatrix, Fatal Outcome, Female, Humans, Immunocompromised Host, Infant, Newborn, Mycobacterium bovis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tuberculosis, Vaccination, Virus Activation